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Abstract
Background: Mycobacterium ulcerans (M. ulcerans) is the causative agent of Buruli Ulcer (BU) disease. In order to
inhibit the growth of the microbial contaminants during culture of M. ulcerans, it is necessary to decontaminate
BU samples with effective chemical agents. This study aimed at investigating some selected chemicals as potential
decontamination agents for the isolation of M. ulcerans from swabs.
Results: Povidone iodine at 0.5 and 1% exhibited the lowest contamination and recovery rate for microbial
contaminants and M. ulcerans. The most effective decontamination method was the protocol using 2%
cetylpyridinium chloride/4% sodium chloride (recovery rate = 53%, contamination rate = 14%). The observed
difference between the recovery rate of 2% CPC/4% NaC and the other protocols was however not
statistically significant (p = 0.76).
Conclusions: Two percent (2%) cetylpyridinium chloride/4% sodium chloride can be conveniently used as an
alternative decontamination method for the isolation of M. ulcerans from swabs.
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Background
Mycobacterium ulcerans (M. ulcerans) causes Buruli
ulcer (BU) disease, the third most common Mycobacter-
iosis after tuberculosis and leprosy [1]. The disease has
been reported in over 30 countries worldwide [2]. In
Ghana, most endemic areas are located in water related
rural farming communities, with limited access to
healthcare. The associated deformities of patients as a
result of the disease, coupled with the socio-economic
effect on members within the affected communities
makes it a public health issue [3]. Women and children
under the age of 15 years are particularly affected [4].
Buruli ulcer disease manifests as skin nodules, papules,
plaques, edema and ulcers. Currently, the BU disease is
treated with rifampicin and streptomycin for an 8 week
period [5]. Prior to the administration of the drugs how-
ever, the World Health Organization (WHO) strongly
recommends that, suspected cases be confirmed by
microbiological methods, including microscopy, culture,
polymerase chain reaction (PCR) and histopathological
analysis of diagnostic specimens from BU lesions [6].
Significant successes have been achieved with the
management of BU disease since it became a global
health challenge. This is as a result of intensive and
extensive solution seeking investigations into a hitherto
difficult situation. Investigations include (i) the extrac-
tion and use of mycolactone, the key virulent factor
mediating Buruli ulcer disease for further research [7, 8],
(ii) availability of information on drug susceptibility
profiles of existing isolates to current antibiotics and
potentially effective ones [9], (iii) M. ulcerans’ viability in
BU lesions post antibiotic treatment, indicative of treat-
ment successes or failures, (iv) molecular epidemiology
of the disease [10] and (v) disease surveillance. Most of
these investigations have relied on M. ulcerans isolates
from culture; a method for growing isolates of viable M.
ulcerans in-vitro. This process therefore remains a very
vital and important tool, for effective disease manage-
ment. The culture process requires the use of diagnostic
specimens from BU lesions. Faster growing microbial
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contaminants in BU lesions overgrow the M.ulcerans
cultures, affecting their yield [11]. The reduction of these
contaminants is usually achieved by processing the samples
with chemical agents having selective antimicrobial proper-
ties in a process referred to as decontamination [12]. Effect-
ive decontamination protocols generally inhibit the growth
of microbial contaminants with little or no inhibitory effect
on viableM. ulcerans [13].
Commonly employed decontamination procedures in the
primary isolation of M. ulcerans include sodium chloride
(Petroff method) [14, 15], oxalic acid [14], N-acetyl cysteine
[15, 16], Sulfuric Acid [16] (Buijtels PC1, Petit PL), benzalk-
onium chloride (BC) [17], trisodium Phosphate [15], sodium
lauryl sulfate [18], and the equivalent 1- Hexadecylpyridi-
nium chloride (HPC) methods [19–21]. To date, almost all
decontamination protocols have their associated challenges
[22, 23]. These include higher toxicity to M. ulceren and
slow processing time due to the reason that most protocols
require a neutralization stage [16, 22].
Diagnostic specimens commonly used for M. ulcerans
isolation include tissue samples, swabs and fine needle
aspirates [10, 24]. Recovery from tissue specimens proc-
essed with 5% oxalic acid remains the highest reported de-
contamination process so far at 78% [25]. The effective
use of antibiotics as definitive BU treatment has limited
the availability of tissue samples [26], making swabs and
fine needle aspirates more convenient alternatives. Decon-
tamination protocols used for swabs should be relatively
less harsh to bacilli in the already paucibacillary specimen.
In addition, large open BU lesions tend to harbour spores
of microbes including fungi and other hardy environmen-
tal microorganisms. To address these challenges, there is
the need to design more decontamination protocols, not
only with the sole objective of inhibiting growth of vegeta-
tive bacteria but also fungal contaminants [27]. Effective
decontamination methods (especially chemical agents
with known antifungal properties) can complement the
commonly used 5% oxalic acid. The current study there-
fore investigated some chemicals as decontamination
agents for the isolation of M. ulcerans from swabs.
Methods
Investigations and sample processing took place at the
Bacteriology Department of the Noguchi Memorial
Institute for Medical Research (NMIMR), University of
Ghana, Legon, Tuberculosis Laboratory of the Public
Health Reference Laboratory (PHRL), of the Ministry of
Health and the chest clinic of the Korle-Bu Teaching
Hospital (KBTH), Korle-Bu. This research was carried
out between the periods June 2010 and April 2012.
Preparation of Buruli ulcer samples and clinical isolates
Exudates from BU lesions of 35 subjects were swabbed
for the study. Subjects were clinically suspected BU
cases who reported at the Paakro and Asuboi health
centers of the Eastern region of Ghana. The selected
samples had been authenticated as being M. ulcerans
positive by microscopy and IS2404 polymerase chain re-
action (PCR). Specimen collection process involved a
circular manipulation of the swab within the periphery
of lesions [27].
Swabs in their receptacles were kept under cold storage
and transported to the laboratory for analysis. Each swab
specimen was eluted in 2 ml (2 ml) of sterile phosphate
buffered saline (PBS) in a 15 ml capacity screw-capped
test tube (3 mm diameter, Merck, Germany) [25].
Buruli ulcer sample for analysis was obtained as an
eluted suspension, facilitated by vortexing swab tips with
10–15 glass beads for a minute. Bacterial clinical isolates
used in the study included Pseudomonas aeruginosa,
Salmonella typhi, Escherichia coli, Bacillus cereus,
Staphylococcus epidermidis, Staphylococcus aureus and
Klebsiella pneumonia. Aspergillus niger and Candida
albicans were the only fungi isolates tested. Each
microbial inoculum was prepared from a loopful of pure
microbial culture emulsified in sterile distilled water to
obtain turbidity comparable to McFarland’s standard
solution 0.5, equivalents to 1×106 bacteria cells/ml.
Chemical agents preparation
Five (5) selected chemical agents, prepared at indicated
working dilutions were used. These were (i) 0.5% povi-
done iodine (PI) [28], (ii) 1% povidone iodine (PI), (iii)
1% cetylpyridinium chloride/2% sodium chloride (iv) 2%
cetyl-pyridinium chloride/4% sodium chloride, (v) 5%
oxalic acid (vi) 10% oxalic acid [29] (vii) 0.5% virkon and
(viii) 1% virkon (ix) 20% benzalkonium chloride and (x)
benzalkonium chloride at 40% [30, 31]. Therefore, two
dilutions each of the 5 chemical agents were prepared
and used. Hence, 10 combinations were used for the
subsequent process. Sterile distilled water was used as
diluents for all chemical agents.
Validating selected chemical agents as effective
antimicrobials
Each of the five chemical agents prepared in the
dilutions indicated was mixed by vortexing with suspen-
sions of microbial inoculums of the potential contami-
nants (P. aeruginosa, S. typhi, E. coli, B. cereus, S.
epidermidis, S. aureus, K. pneumonia, A. niger and C.
albicans) in equal volumes of 200 μl per test. Inoculums
and chemical agents were vortexed for a minute and in-
cubated at room temperature for 15 min with intermit-
tent mixing. This process was aimed at ensuring even
distribution and exposure. One Hundred microliters
(100 μl) of each test was inoculated onto Mueller-Hinton
(MH) agar plates and evenly spread to ensure uniformity
after which the plates were incubated at 37 °C for 24 h. A
Owusu et al. BMC Microbiology  (2017) 17:2 Page 2 of 7
test showing no growth was indicative of an effective
inhibitory effect of the tested chemical agents at the pre-
pared dilution.
Inhibitory effect of chemical agents on microbial
contaminants in BU samples
Benzalkonium chloride was the only chemical agent that
did not go through the validation stage successfully.
Therefore, four successfully validated chemical agents
were subsequently tested for their antimicrobial activity
against microbial contaminants in BU samples. This
implies that the number of chemical agents used for the
study became 4 and in two dilutions each, making it 8
combinations. In brief, samples were obtained as
swabbed exudates and pus from the periphery and
crevices of the ulcers. Sample suspensions were obtained
by agitating swab tips in fixed volume (2 ml) of sterile
phosphate buffered saline and glass beads. The suspen-
sion was then aseptically transferred to another sterile
tube. For each of the suspensions an adjusted turbidity
comparable to MacFarlands standard solution 1 was
used. Chemical agents were mixed with BU sample sus-
pensions in equal volumes of 400 μl. Tests were
vortexed to ensure adequate exposure, and incubated at
room temperature for 15 min. One hundred microliters
(100 μl) of well mixed test was inoculated on Mueller
Hinton agar plates and incubated at 37 °C for 24 h.
Media plates showing no growth was indicative of the
antimicrobial effect of the chemical agent on the
microbial contaminants in the BU samples.
Examination of chemicals as effective decontamination
agents
The selected chemical agents at the specified dilutions
were investigated for their potential as suitable decon-
tamination agents for the recovery of M. ulcerans from
swab specimens [32].
Two milliliters (2 ml) aliquots of the sample homoge-
nates were subjected to eight decontamination protocols
using four chemical agents. The protocols were cetylpyr-
idinium chloride at concentrations of 0.5 and 1%, povi-
done iodine antiseptic at concentrations of 0.5 and 1%,
oxalic acid at concentrations of 5 and 10%, and virkon
disinfectant at concentrations of 0.5 and 1%. Briefly,
each of the test samples was incubated for 30 min under
room temperature conditions after which they were
centrifuged at 3000 rpm for 15 min. The supernatant
was discarded and the pellet obtained re-suspended in
1.0 mL of sterile phosphate buffered saline (PBS) solu-
tion to obtain sample inoculums. Each sample inoculum
(100 μL) was seeded on Lowenstein-Jensen (L-J) slants
in duplicates and gently spread over the surface. The
tubes were loosely covered and examined daily until the
media surface was completely dried. They were then
tightly capped, arranged at a slanted angle of 30° and
incubated at 32 °C. The cultures were examined weekly
for the growth of contaminants and M. ulcerans (slow-
growers) for 12 weeks. The M. ulcerans colonies were
identified by conventional laboratory methods [33] by
subjecting the cultures with growth to Ziehl-Neelsen
staining and a confirmatory IS2404 PCR [33]. Cultures
showing no M. ulcerans growth after 12 weeks were
considered negative, whilst those with growth were
considered positive. Contaminated cultures were those
exhibiting over 50% growth coverage of colonies other
than that of M. ulcerans. Chemicals assessed as effective
decontamination agents were the tests that exhibited
high M. ulcerans recovery and low contamination rates.
Controls for media, chemical agents and bacteria were
set alongside all three experimental processes; testing
the selected chemical agents (on test organisms) as
effective antimicrobials, examination for their antimicro-
bial activity against microbial contaminants in BU sam-
ples and their potential as suitable decontamination
agents for the recovery of M. ulcerans from swab speci-
mens. They were incubated and read simultaneously
with the tests at 32 °C [34].
Data analyses
Data from this study was stored in Microsoft excel (MS
Excel) and analyzed with STATA 11 (Strata Corp,
College Station, TX). Data analysis involved descriptions
of estimated totals, arithmetic means, ranges and preva-
lence rates of the study variables. Association between
the protocols was determined using the chi-square (χ2)
test, and based on 95% confidence interval. A P-Value
less than 0.05 was considered statistically significant.
Results
Validation of selected chemicals as effective antimicrobial
agents displayed various levels of activity against the test
bacterial isolates (P. aeruginosa, S. typhi, E. coli, Bacillus
cereus Staphylococcus epidermidis, Staphylococcus aureus,
K. pneumoniae) and fungal isolates (A. niger and C.
albicans) (Table 1). All the test microbes were susceptible
to both concentrations of povidone iodine (Table 1). E.
coli, P. aeruginosa and S. typhi exhibited resistance to 1%
CPC/2% NaCl whilst Bacillus cereus and A. niger exhib-
ited resistance to 5% oxalic acid. Virkon disinfectant at
0.5% exhibited antimicrobial activity against all except
A. niger (Table 1). Meanwhile, 20% BC (Timsen) and
40% BC (Timsen) had no antimicrobial activity
against P. aeruginosa, B. cereus and A. niger.
Various degrees of growth inhibition on the samples
were observed for the thirty five (35) BU samples
(processed in duplicates to get a total of 70 samples and)
tested with the selected chemical agents. Levels of inhib-
ition which shows how many of plates were inhibited
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out of the 70 by a particular protocol ranged between
86% (60/70) and 100% (70/70). The highest levels of in-
hibition was exhibited by 0.5% povidone iodine and 1%
povidone iodine; 97% (68/70 plates) and 100% (70/70
plates) respectively. The activities of the chemical agents
against the microbial sample contaminants were esti-
mated based on the level of growth inhibition exhibited
by test plates. The lowest level of 86% of antimicrobial
activity was exhibited by 20% benzalkonium chloride
(BC). Five percent oxalic acid exhibited an activity level
of 91%.
A summary of the effect of the eight decontamination
protocols investigated against 35 BU sample suspensions
(prepared in duplicates) for the primary isolation of M.
ulcerans from the BU samples is shown in Table 2. The
recovery rates ranged between 0 and 53%. The highest
M. ulcerans’ recovery rate was by 2% CPC/4% NaCl at
53% whilst the lowest was by 0.5 and 1% povidone
iodine (Table 2). The rate for 5% oxalic acid was 44%.
The secondary contamination rates of the M. ulcerans
cultures were assessed for the various protocols. The
least rate of secondary contamination was observed in
all the two dilutions of povidone iodine (Table 2). The
highest rate (29%) of secondary contamination was re-
corded for the conventional (5% oxalic acid) decontam-
ination protocol followed by 1% CPC/2% NaCl (21%)
(Table 2).
Discussion
A major challenge in the primary isolation of M. ulcer-
ans is contamination by fast growing microbes. Swab
specimens, a more convenient diagnostic specimen tend
to have lower yields due to limitations in sample collec-
tion. Optimization based studies aimed at complement-
ing current decontamination protocols are essential.
This study therefore investigated five chemicals for their
effectiveness as decontamination agents in isolating M.
ulcerans from swabs. Among the chemical agents inves-
tigated was the currently used 5% oxalic. The study was
designed to preliminarily validate their effect on some
likely bacterial and fungal skin contaminants. Among
the bacterial contaminants were Bacillus cereus, E. coli,
K. pneumoniae, K. species, P. aeruginosa, S.typhi, S.
epidermidis and S. aureus. Candida albicans and
Table 1 Inhibitory effect of selected chemical agents on clinical isolates of Potential skin contaminants
Chemical agents In-vitro resistance of microbes
to chemical agentsa
Test plates showing no
growth, n (N = 70)
Estimated activity levels
of chemical agents (%)
0.5% PI None of the microbes tested 68 97
1% PI None of the microbes tested 70 100
1% CPC/2% NaCl E. coli, P. aeruginosa & S. typhi 65 92
2% CPC/4% NaCl None of the microbes tested 67 95
5% Oxalic acid B. cereus & A. niger 64 91
10% Oxalic acid None of the microbes tested 67 96
0.5% Virkon A. niger 67 96
1% Virkon None of the microbes tested 67 96
20% BC (Timsen) P. aeruginosa, B. cereus & A. niger 60 86
40% BC (Timsen) P. aeruginosa & A. niger 63 90
PI Povidone iodine, CPC Cetyl pyridinium chloride, NaCl Sodium chloride, BC Benzalkonium chloride
aTest microbes were P. aeruginosa, S. typhi, E. coli, Bacillus cereus, S. epidermidis, S. aureus, K. pneumonia, A. niger and C. albicans. % = n/N × 100
Table 2 Effect of protocols on the recovery of M. ulcerans from BU samples, in-vitro
Decontamination
protocols








0.5% PI 0 0 (0.00) 0 0 (0.00)
1% PIb 0 0 (0.00) 0 0 (0.00)
1% CP/2% NaCl 33 47 (0.00) 15 21 (0.00)
2% CPC/4% NaCl 37 5 3(0.76) 10 14 (0.00)
5% Oxalic acid 31 44 (0.07) 20 29 (0.00)
10% Oxalic acid 10 14 (0.00) 12 17 (0.00)
0.5% Virkon 36 51 (0.40) 12 17 (0.00)
1% Virkon 6 0.1 (0.00) 7 10 (0.00)
an = total number of tests: 35 × 2 = 70,
bConventional method, BU Buruli ulcer, PI Povidone iodine, CPC Cetyl pyridinium chloridem, NaCl Sodium chloride
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Aspergillus niger were the fungal contaminants used in
the validation. Microbial contaminants isolated from BU
samples collected for the study were also used in the
validation process.
All tested chemical agents demonstrated varying degrees
of inhibition against the isolates at their prepared dilu-
tions. The effectiveness of povidone iodine and virkon as
antimicrobial agents was clearly seen; as they exhibited
the highest activity at 98 whilst 20% benzalkonium
chloride (an antiseptic for the cleaning of diabetic
wounds) showed the lowest activity at 86%. In spite of
high activity recorded by some of the chemical agents, P.
aeruginosa and A. niger proved to be the most challenging
to inhibit among all the microbial isolates tested. This
finding brings to the fore the intrinsic resistance proper-
ties exhibited by P. eruginosa to most antimicrobials [11].
Similar observations were made by McClean et al. [11],
where they also observed that P. aeruginosa was the pre-
dominant contaminant associated with the conventional
isolation of Mycobacterium tuberculosis. That study also
reported that 5% oxalic acid alone and in combination
with NaOH was effective in eliminating P. aeruginosa
[11]. The challenge in eliminating Aspergillus niger with
the chemical agents used in the current study could be at-
tributed to the fact that, most vegetative fungi and fungal
spores are more resistant to decontamination agent.
Biocide-microbial interaction usually occurs at the surface
with little impact on the fungi, as few biocides are
intended to focus on fungus cell as a major target.
The highest mean recovery of M. ulcerans from culture
was exhibited by 2% cetyl pyridinium chloride/4% sodium
chloride (53.0%) and 0.5% virkon (51.0%) treated samples,
and the lowest was observed in samples treated with 0.5 and
1% povidone iodine (0%). The recovery rate of 1% cetyl pyri-
dinium chloride/2% sodium chloride and 5% oxalic acid
were comparable at 44 and 41% respectively. This recovery
rates are relatively less than 0.5 and 1% virkon disinfectant
and 2% CPC/4% NaCl. In this study, M. ulcerans yield from
5% oxalic acid was comparatively lower at 41%. This obser-
vation conforms to outcome from similar study conducted
by Palomino and Portaels [14], where they observed a
marked reduction in the growth rate of M. ulcerans in cul-
ture due to the harmful effect of oxalic acid on the culture
of M. ulcerans from the BACTEC system [14]. Other inves-
tigators have however reported on high yields with the use
of 5% oxalic acid. In a study by Yajko et al. [35], where they
worked on fecal samples cultured on Lowenstein-Jensen
media to evaluate various chemical decontamination proto-
cols, they reported that the highest yield of Mycobacterium
avium complex (MAC) was with oxalic acid [35]. Another
study conducted in Ghana using 5% oxalic acid gave an M.
ulcerans isolation rate of 78% from tissue [25], and this is
relatively higher compared to the 41% recovery rate
observed for 5% oxalic acid from swabs.
The observed differences in the various studies includ-
ing the current one appear to be due to various factors
such as specimen types and treatment processes used, in
addition to the array of selected chemical agents used for
the evaluation studies. This study on the other hand, used
swab specimens from open ulcers, cultured on
Lowenstein-Jensen media. This confirms the variability of
outcomes for recovery of M. ulcerans from culture, based
on the specimens and the media used. The implication
could be that whilst the decontamination step is very im-
portant for M. ulcerans’ recovery, other factors could also
affect the yield. In addition, it is possible that heavily con-
taminated specimens would require harsher treatments,
but could also affect the viability of the target organism
(M. ulcerans) in the sample.
Cetyl pyridinium chloride in sodium chloride though
comparatively less harsh than povidone iodine, exhibited
the best M. ulcerans recovery rate in this study. This
phenomenon may be attributed to the antifungal
properties of CPC/NaCl [20, 27] and its usefulness for the
transport of specimens from peripheral centers to the ref-
erence laboratories for analysis, especially in under-
resourced endemic areas [19]. Anti-Fungal agents control
the overgrowth of fungi, which characteristically spread at
a rapid rate over the media surface. This implies that
decontamination protocols incorporating anti-fungal
properties will be required for effective decontamination.
This study has demonstrated that, single decontamin-
ation protocol only cannot improve the recovery of M.
ulcerans from clinical specimens, especially swabs. In
the culture of slow growing Mycobacterium, cultures are
examined on a daily basis for 7 days for the presence of
faster growing microbial contaminants. Even though
povidone iodine was preliminarily validated as an effect-
ive antimicrobial agent against all contaminants tested,
no colonies of M. ulcerans were observed. This outcome
could be due to the fact that povidone iodine has a ster-
ilizing effect in culture; property that made it unsuitable
as a decontamination agents at the dilutions investigated
in the current study. This observation corroborates the
fact that, in investigating potentially novel decontamin-
ation protocols, a stepwise approach of validating its
effect as a decontaminant at the specified dilution would
be required. This would help reduce errors associated
with the selection of appropriate decontamination proto-
cols based on the premise that effective antimicrobial
agents are by extension effective decontamination agents
for the isolation of Mycobacterium. In addition,
optimization of decontamination protocols for the
isolation of Mycobacterium species would require the
use of lower concentrations of the test agent and longer
periods of exposure.
In a different study, Smithwick et al. [19] found 1%
cetyl pyridinium chloride/2% sodium chloride useful for
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the transport of sputum specimens from peripheral to refer-
ence laboratories. They observed that its effect was compar-
able to the conventionally used Nacetyl- L-cysteine. Results
from this study corroborated his observation and also found
it useful. Whilst the 1% povidone iodine protocol did not
yield any M. ulcerans from culture, it recorded no contam-
ination. This was also observed for 1% virkon disinfectant.
Meanwhile, the highest rate (29%) of secondary contamin-
ation was recorded for the conventional (5% oxalic acid)
protocol. Although this is a strong decontamination proto-
col, experimental period of exposure and low a concentra-
tion of agent in the culture medium may contribute to this
contamination rate [11].
To the best of our knowledge, the use of povidone
iodine and virkon as a decontamination agent in the pri-
mary isolation of Mycobacterium ulcerans in this study
represents the first attempt to evaluate these chemical
agents. The decontamination protocols utilizing the two
concentrations of povidone iodine seems to affect not
only the viability of the contaminating microbes, but it
also inhibits the growth of the M. ulcerans in culture.
This informs future projections where povidone iodine
could be used at relatively lower concentrations to
achieve more desirable results. Also, this study reports
the effective use of 0.5% virkon, a broad spectrum
disinfectant for the isolation of M. ulcerans from swabs.
Conclusions
Effective means of isolating M. ulcerans from diagnostic
specimens, particularly swabs is required for control of
BUD. This will inform policy on effective disease control
measures targeted at reducing BU cases. The current re-
search has demonstrated that, 2% cetylpyridinium
chloride/4% sodium chloride can be conveniently used as
an alternative decontamination method for the isolation
of M. ulcerans from swabs. This can contribute towards
effective diagnosis and control of BU disease, worldwide.
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